JG-2016

CAS No. 2887480-87-5

JG-2016( —— )

Catalog No. M37309 CAS No. 2887480-87-5

JG-2016, as a small molecule histone acetyltransferase 1 (HAT1) inhibitor, inhibits the growth of human cancer cell lines, inhibits enzyme activity in cellulose, and interferes with tumor growth.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 179 Get Quote
5MG 282 Get Quote
10MG 455 Get Quote
25MG 877 Get Quote
50MG 1408 Get Quote
100MG 1782 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    JG-2016
  • Note
    Research use only, not for human use.
  • Brief Description
    JG-2016, as a small molecule histone acetyltransferase 1 (HAT1) inhibitor, inhibits the growth of human cancer cell lines, inhibits enzyme activity in cellulose, and interferes with tumor growth.
  • Description
    JG-2016 is a potent inhibitor of histone acetyltransferase 1 (HAT1), with an IC50 of 14.8 μM in the HAT1 acetylation assays.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Histone Acetyltransferase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2887480-87-5
  • Formula Weight
    376.84
  • Molecular Formula
    C18H21ClN4O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (265.36 mM; Ultrasonic )
  • SMILES
    O=C1N=C2C(=NC=3C=C(Cl)C(=CC3N2CCOCC(C)C)CC)C(=O)N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Joshua James GRUBER, et al. Modulators of histone acetyltransferase 1 and methods of treatment thereof. Patent, WO2022272313A1.
molnova catalog
related products
  • BIM-46187 4HCl

    PH-064 4HCl is a heterotrimeric G-protein complex inhibitor.

  • Ribonuclease A

    Ribonuclease A (RNase A) is a potent endonuclease that removes RNA during dna and protein preparation.

  • CPI-1189

    REN-1189 is a TNF-a release inhibitor potentially for the treatment of sciatica and postherpetic neuralgia.